The submission period has ended
Call for Proposals
25 Mar 2024 - Submission Opens
20 May 2024 - Submission Deadline
28 Jun 2024 - Notifications Sent
Why attend?
The 2024 ISPE Pharma 4.0™ and Annex 1 Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on digital transformation, automation, and the evolving landscape and future of Pharma 4.0™ supported Aseptic Manufacturing.
The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical chain. These sessions and workshops will showcase recent innovations and trends, and directly discuss practical challenges and solutions, from a technical, logistical, and regulatory perspective. The impact of Quality Risk Management (QRM) and Contamination Control Strategy (CCS) regulations, in particular for Annex 1, will be integrated throughout the conference programme and discussions. Participants will have the opportunity to engage with industry leaders, regulators, and peers through networking events and the conference programme.
Your Conference Experience
Expo Hall
Expo Hall
Explore groundbreaking innovations and network with industry leaders at our dynamic expo hall.
Networking
Networking
Connect with top industry experts and expand your professional network at our exclusive networking sessions.
Live Streams
Live Streams
Experience the conference from anywhere with our interactive live stream.
On-Demand Content
On-Demand Content
Access exclusive conference content anytime with our on-demand library for 90 days.
Conference Gallery
International Program Committee
Senior Consultant Aseptic Processing & Containment
SKAN AG
Managing Consultant, Compliance Consulting
NNE
Vice President Vetter Development Service External Affairs
Vetter Pharma Fertigung GmbH & Co KG
Senior Director, Global Engineering & Technology
Johnson & Johnson
Vice President Strategic Development, Marketing & Communication - Partner
PQE Group
Quality Fundamentals Area Lead
Roche
Director, Head of Novel Modalities Development EMEA
Merck KGaA
Fellow - Digital Technology, Associate
CRB
Regulatory Advisor
ISPE
Managing Director
Q-FINITY Quality Management
Senior Industry Advisor and Principal Consultant for Advanced Therapies
Körber Pharma Software Inc
Founder & CEO
LifeBee - Digitalizing Life Sciences
Vice President QA International
Cencora
Corporate Program Manager
Menarini
Managing Director
Memo3 GmbH
Executive Industry Advisor
Körber Pharma Software GmbH
Quality Assurance Project Manager
Lonza AG
Project Advisor
Aseptic Mind
Process Engineer
VTU Engineering GmbH
Network Technology Robotics Lead
F Hoffmann-La Roche AG
Managing Director
Memo3 GmbH
PhD Candidate
Karlsruhe Institute of Technology (KIT)